Abbott Laboratories’s recently made public that its Officer Funck, Jr. Robert E. acquired Company’s shares for reported $1.8 million on Nov 04 ’24. In the deal valued at $120.00 per share,15,000 shares were bought.
Then, ALLEN HUBERT L sold 157,421 shares, generating $18,424,298 in total proceeds. Upon selling the shares at $117.04, the EXECUTIVE VICE PRESIDENT now owns 184,806 shares.
Before that, ALLEN HUBERT L bought 157,421 shares. Abbott Laboratories shares valued at $18,715,783 were divested by the Officer at a price of $118.89 per share.
Oppenheimer initiated its Abbott Laboratories [ABT] rating to an Outperform in a research note published on October 08, 2024; the price target was $130. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in mid September with a ‘”an Overweight”‘ rating. Edward Jones also remained covering ABT and has decreased its forecast on July 30, 2024 with a “Hold” recommendation from previously “Buy” rating. Goldman started covering the stock on May 30, 2024. It rated ABT as “a Buy”.
Price Performance Review of ABT
On Friday, Abbott Laboratories [NYSE:ABT] saw its stock fall -1.70% to $112.31. Over the last five days, the stock has lost -1.00%. Abbott Laboratories shares have fallen nearly -0.71% since the year began. Nevertheless, the stocks have fallen -0.37% over the past one year. While a 52-week high of $121.64 was reached on 01/07/25, a 52-week low of $99.71 was recorded on 01/10/25. SMA at 50 days reached $115.30, while 200 days put it at $110.57.
Levels Of Support And Resistance For ABT Stock
The 24-hour chart illustrates a support level at 111.45, which if violated will result in even more drops to 110.60. On the upside, there is a resistance level at 113.50. A further resistance level may holdings at 114.70. The Relative Strength Index (RSI) on the 14-day chart is 40.94, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.41, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 77.94%. Stochastics %K at 49.75% indicates the stock is a holding.
How much short interest is there in Abbott Laboratories?
A steep rise in short interest was recorded in Abbott Laboratories stocks on 2024-12-13, growing by 47947.0 shares to a total of 12.1 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 12.05 million shares. There was a rise of 0.4%, which implies that there is a positive sentiment for the stock.
